Table 3.

Sixteen nonamers predicted from the results of positional scanning synthetic combinatorial library screen

PositionP1P2P3P4P5P6P7P8P9
Amino acidYLLPMVVSV
WYTP
Peptide namePeptide sequenceConcentration, nM
44 H- Y L V S 0.00005 
46 H- Y L T S 0.0005 
54 H- Y L W T S 0.5 
56 H- Y L W Y V S 50 
47 H- Y L T P 500 
52 H- Y L W V S 500 
53 H- Y L W V P 500 
55 H- Y L W T P 500 
58 H- Y L W Y T S 500 
45 H- Y L V P > 500 
48 H- Y L Y V S > 500 
49 H- Y L Y V P > 500 
50 H- Y L Y T S > 500 
51 H- Y L Y T P > 500 
57 H- Y L W Y V P > 500 
59 H- Y L W Y T P > 500 
pp65495-503 H- 0.5 
pp65495-503 H- 0.5 
PositionP1P2P3P4P5P6P7P8P9
Amino acidYLLPMVVSV
WYTP
Peptide namePeptide sequenceConcentration, nM
44 H- Y L V S 0.00005 
46 H- Y L T S 0.0005 
54 H- Y L W T S 0.5 
56 H- Y L W Y V S 50 
47 H- Y L T P 500 
52 H- Y L W V S 500 
53 H- Y L W V P 500 
55 H- Y L W T P 500 
58 H- Y L W Y T S 500 
45 H- Y L V P > 500 
48 H- Y L Y V S > 500 
49 H- Y L Y V P > 500 
50 H- Y L Y T S > 500 
51 H- Y L Y T P > 500 
57 H- Y L W Y V P > 500 
59 H- Y L W Y T P > 500 
pp65495-503 H- 0.5 
pp65495-503 H- 0.5 

Nonamer peptides with the substitutions as shown at each position were synthesized as described in “Materials and methods.” Substitutions predicted by the library screen of TCC 3-3F4 are shown on top of the table, immediately below each residue P of the CTL epitope, and the native sequence of the pp65495-503 CTL epitope is shown at the bottom of the table. Results of CRA are shown using peptide-sensitized HLA-A

F3-150

0201–restricted EBVLCLs as target cells and TCC 3-3F4 effectors at an E/T ratio of 5. The terminus for each peptide and for pp65495-503 is −NH2, and the terminus for pp65495-503 is −OH. The concentration of peptide, in which specific killing was between 15% and 30%, represents the average results from at least 3 independent experiments carried out on different days using different batches of TCC-3F4. Peptides were tested using 10-fold dilutions ranging from 500-0.00005 nM.

CTL indicates cytotoxic T-lymphocyte; CRA, chromium release assay; EBVLCLs, Epstein-Barr virus–transformed B cell lines; E/T, effector-to-target; for other abbreviations, see Table 1.

or Create an Account

Close Modal
Close Modal